Gail J Maderis's Net Worth
$22 Thousand
Who is Gail J Maderis?
Gail J Maderis does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DURECT CORP, Allarity Therapeutics, Inc., NovaBay Pharmaceuticals, Inc., and Opexa Therapeutics, Inc..
SEC CIK
Gail J Maderis's CIK is 0001503147
Past Insider Trading and Trends
2015 was Gail J Maderis's most active year for acquiring shares with 9 total transactions. Gail J Maderis's most active month to acquire stocks was the month of December. 2015 was Gail J Maderis's most active year for disposing of shares, totalling 1 transactions. Gail J Maderis's most active month to dispose stocks was the month of March. 2022 saw Gail J Maderis paying a total of $135,135.25 for 255,000 shares, this is the most they've acquired in one year. In 2015 Gail J Maderis cashed out on 8,242 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DURECT CORP (DRRX) Snapshot price: $0.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +14.42% | 25.2K |
$0.71 | $17,993.14 | 200K |
Aug 12
| |||
Form 4
|
∞
| 174.8K |
$0.67 | $117,142.10 | 174.8K |
Aug 9 - Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allarity Therapeutics, Inc. (ALLR) Snapshot price: $0.4602
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NovaBay Pharmaceuticals, Inc. (NBY) Snapshot price: $0.1331
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Opexa Therapeutics, Inc. (ACER) Snapshot price: $0.6601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.22% | 6.46K |
—
|
—
| 25.88K |
Sep 30
| |||
Form 4
| +49.75% | 6.46K |
—
|
—
| 19.43K |
Jun 30
| |||
Form 4
| +99.02% | 6.46K |
—
|
—
| 12.97K |
May 16
| |||
Form 4
| +26.21% | 1.35K |
—
|
—
| 6.52K |
Dec 31
| |||
Form 4
| +30.26% | 1.2K |
—
|
—
| 5.17K |
Sep 30
| |||
Form 4
| +36.16% | 8.43K |
—
|
—
| 31.73K |
Jun 30
| |||
Form 4
| +54.73% | 8.24K |
—
|
—
| 23.3K |
Apr 8
| |||
Form 4
| +82.72% | 6.82K |
—
|
—
| 15.06K |
Mar 30 - Mar 31
| |||
Form 4
|
∞
| 8.24K |
—
|
—
| 8.24K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||